Hjem › Blærekreft › Michigan › Grand Rapids
Kliniske studier for Blærekreft i Grand Rapids, MI
12 studier for Blærekreft søker deltakere på steder i og rundt Grand Rapids (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruttererFase 1
- START Midwest Cancer and Hematology Centers of W Michigan, Grand Rapids
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekruttererFase 1/2
- START Midwest, Grand Rapids
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
RekruttererFase 1
- START Midwest, Grand Rapids
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekruttererObservasjonsstudie
- Cancer & Hematology Centers of Western Michigan, Grand Rapids
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
RekruttererFase 2/3
- Research Site, Grand Rapids
Measuring Surgical Recovery After Radical Cystectomy
RekruttererObservasjonsstudie
- Spectrum Health Medical Group, Grand Rapids
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
RekruttererFase 3
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital, Grand Rapids
- Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids
- Trinity Health Grand Rapids Hospital, Grand Rapids
A Study of MGC026 in Participants With Advanced Solid Tumors
RekruttererFase 1
- START Midwest, Grand Rapids
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RekruttererFase 1/2
- Corewell Health Medical Group and Spectrum Health Hospitals, Grand Rapids
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
RekruttererFase 2
- The Cancer & Hematology Centers, Grand Rapids
- Cancer & Hematology Centers of Western Michigan, PC- Kit Storage, Grand Rapids
- The Cancer & Hematology Centers, Grand Rapids
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- START Midwest, Grand Rapids
Blærekreft-studier i andre byer
- New York City, NY35 studier
- Nashville, TN31 studier
- Houston, TX31 studier
- Dallas, TX27 studier
- Washington, DC26 studier
- Boston, MA26 studier
- Baltimore, MD24 studier
- Los Angeles, CA24 studier
- St. Louis, MO22 studier
- Seattle, WA21 studier
- Chicago, IL21 studier
- Philadelphia, PA21 studier
Andre studier i Grand Rapids
- Ikke-småcellet lungekreft44 studier
- Kolorektal kreft40 studier
- Kreft (alle typer)28 studier
- Brystkreft26 studier
- Eggstokkreft24 studier
- Metastatisk kreft22 studier
- Prostatakreft19 studier
- Endometriekreft18 studier
- Mavekreft18 studier
- Pankreaskreft18 studier
- Melanom17 studier
- Plateepitelcancer i hode og hals15 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.